Discovery of novel 4-arylamino-quinazoline derivatives as EGFRL858R/T790M inhibitors with the potential to inhibit the non-small cell lung cancers
- Resource Type
- Article
- Source
- In
Bioorganic Chemistry October 2022 127 - Subject
- Language
- ISSN
- 0045-2068